IP Library Patent Application 18258101
Patent Application
App. No. 18/258,101

CELLULAR HEALTH NUTRITIONAL PRODUCT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/258,101
Abstract

A nutritional supplement composition formulated having antioxidant and anti-inflammatory nutrients reduces cellular biomarkers of DNA damage and improves cellular regenerative capacity.

Claims (15)

1 . A composition for oral delivery to a subject comprising Vitamin C, Vitamin E and Selenium.

2 . The composition according to claim 1 , further comprising one or more of: carnosine, curcumin, hesperidin, lycopene and lutein.

3 . A method for lessening the rate of cellular damage to DNA of the subject comprising administering the composition of claim 2 .

4 . A method for reducing reactive nitrogen species (RNS) and/or reactive oxygen species (ROS) present in the subject comprising administering the composition of claim 2 .

5 . A method for ameliorating a cellular biomarker of DNA damage in the subject comprising administering the composition of claim 2 .

6 . The method of claim 5 , wherein the cellular biomarker is at least one selected from the group consisting of: Micronucleus (MN) frequency in lymphocytes and buccal cells, TL in lymphocytes and buccal cells, nucleoplasmic bridges, and nuclear buds.

7 . A method for increasing TL in lymphocytes and buccal cells comprising administering the composition of claim 2 .

8 . A method for reducing Micronucleus (MN) frequency in lymphocytes and buccal cells comprising administering the composition of claim 2 .

9 . A method to reduce abnormal cellular methylation of DNA comprising administering the composition of claim 2 .

10 . A method for increasing lipid homeostasis comprising administering the composition of claim 2 .

11 . A method for decreasing abnormal cell division comprising administering the composition of claim 2 .

12 . A method for decreasing protein oxidation comprising administering the composition of claim 2 .

13 . A method for decreasing DNA oxidation and breakage comprising administering the composition of claim 2 .

14 . A method for decreasing lipid peroxidation comprising administering the composition of claim 2 .

15 . A method for decreasing cellular inflammation comprising administering the composition of claim 2 .

Assignments (2)
CHANGE OF NAME Recorded Jan 18, 2024
From: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: HALEON US HOLDINGS LLC
Reel/Frame 066344/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2023
From: BULL, CAROLINE FELICITY; FENECH, MICHAEL; POXON, SCOTT WILLIAM; VAN KLINKEN, BERNARDUS JAN-WILLEM
To: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Reel/Frame 065305/0647 →